Monday, September 11, 2017
AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
ALBANY, N.Y. , March 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and oncology/surgery, today announced it has received CE Mark certification for the Solero Microwave...

  Monday, September 11, 2017
AngioDynamics to Present at the Barclays Global Healthcare Conference
ALBANY, N.Y. , March 08, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2017 Second Quarter Results
Q2 net sales of $89.0 million , down 0.3% year-over-year Q2 GAAP earnings per share of $0.37 ; non-GAAP adjusted EPS up 36% from Q2 Fiscal 2016 Q2 operating cash generation of $14.9 million ; free cash flow generation of $13.6 million Reiterated FY2017 revenue guidance; increased adjusted EPS and...

  Monday, September 11, 2017
AngioDynamics to Participate in 35th Annual J.P. Morgan Healthcare Conference
ALBANY, N.Y. , Jan. 03, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer and...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2017 Second Quarter Financial Results
ALBANY, N.Y. , Dec. 20, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 second...

  Monday, September 11, 2017
AngioDynamics to Participate in Upcoming Investor Conferences
ALBANY, N.Y. , Nov. 28, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics Announces Pricing of Secondary Offering by Selling Stockholders
ALBANY, N.Y. , Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the pricing of the previously announced...

  Monday, September 11, 2017
AngioDynamics Announces Secondary Offering of 2,500,000 Shares of Common Stock by Selling Stockholders
ALBANY, N.Y. , Nov. 14, 2016 (GLOBE NEWSWIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) (the "Company"), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that certain of its stockholders (the...

  Monday, September 11, 2017
AngioDynamics Announces New Senior Credit Facilities and New Share Repurchase Program
New Senior Credit Facility Includes a $100 Million TLA and a $150 Million RCF Board of Directors Authorizes Up to $25 Million in Share Repurchases ALBANY, N.Y. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for...

  Monday, September 11, 2017
AngioDynamics Announces Addition of New Board Members: Eileen Auen, Former Executive Chairman of Helios and Jan Stern Reed, Former General Counsel and Corporate Secretary at Walgreens Boots Alliance, Inc.
ALBANY, N.Y. , Nov. 09, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the appointment of Eileen Auen and Jan Stern Reed to the...

  Monday, September 11, 2017
AngioDynamics to Present at the 2016 Canaccord Genuity Medical Technologies and Diagnostics Forum
ALBANY, N.Y. , Nov. 07, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics Reports Fiscal 2017 First Quarter Results
Q1 net sales of $88.1 million , up 5% year-over-year Q1 GAAP earnings per share of $0.04 ; non-GAAP adjusted EPS of $0.17 Q1 operating cash generation of $7.4 million FY2017 guidance remains unchanged ALBANY, N.Y. , Oct. 05, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider...

  Monday, September 11, 2017
AngioDynamics to Report Fiscal 2017 First Quarter Financial Results
ALBANY, N.Y. , Sept. 21, 2016 (GLOBE NEWSWIRE) -- AngioDynamics  (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2017 first...

  Monday, September 11, 2017
AngioDynamics to Present at the 2016 Morgan Stanley Global Healthcare Conference
ALBANY, N.Y. , Sept. 06, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...

  Monday, September 11, 2017
AngioDynamics to Present at the 2016 Canaccord Genuity Growth Conference
ALBANY, N.Y. , Aug. 08, 2016 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Jim Clemmer , President and Chief Executive Officer, is...